WEST
VALLEY CITY, Utah, Sept. 9,
2024 /PRNewswire/ -- Scientia Vascular, a leader in
neurovascular innovation, is pleased to announce the closing of a
$14 million growth financing led by
Piper Sandler Merchant Banking. The financing will enable Scientia
to continue commercializing the next generation of neurovascular
tools, offering new possibilities for treating a variety of
neurovascular disease states for the benefit of patients.
Through cutting-edge innovation, Scientia is advancing the way
diseases of the cerebral vasculature are treated. Renowned for
disrupting the industry with microfabrication, Scientia currently
offers the most comprehensive portfolio of neurovascular guidewires
on the market and has applied the same groundbreaking technologies,
design principles, and precision machinery to develop highly
differentiated micro catheters and aspiration catheters. As
Scientia moves ahead, microfabrication will continue to serve as
the platform for innovating technologies that address a wide array
of neurovascular disease states more effectively.
Tom Schnettler, managing director
at Piper Sandler Merchant Banking, said, "Scientia exemplifies many
of the attributes we look for in an investment partner: a strong
team with a long track record of innovation and success,
differentiated and groundbreaking technology that improves patient
outcomes, a large and growing market opportunity and strong
financial performance. We look forward to partnering with
John Lippert and the rest of the team at Scientia to support
the next stage of the company's growth."
"Our mission at Scientia is to develop and apply
state-of-the-art technology to care for patients with unmet needs.
We are grateful for the support of Piper Sandler Merchant Banking
as we look to accelerate our growth following the launch of our
Plato 17 and Socrates 38 neurovascular catheters," said
John Lippert, founder and CEO of Scientia.
About Scientia Vascular:
Scientia Vascular is committed to enhancing patient care through
innovative medical devices. With a focus on neurovascular
advancements, Scientia Vascular remains at the forefront of
technological breakthroughs in the medical field.
About Piper Sandler Merchant Banking:
Piper Sandler Merchant Banking (PSMB) is the growth equity
investment arm of Piper Sandler Companies (NYSE: PIPR). The
PSMB team strives to partner with founders and CEOs of growing,
commercial stage businesses that can benefit by
leveraging Piper Sandler's knowledge, experience, capital
and relationships to build market leading enterprises. PSMB
provides investment advisory services through the affiliated
registered investment adviser, PSC Capital Partners
LLC. Learn more about Piper Sandler Merchant
Banking.
For more information, contact:
Larry Myres
President
Scientia Vascular, Inc.
Larry.myres@scientiavascular.com
760.889.4649
View original content to download
multimedia:https://www.prnewswire.com/news-releases/scientia-vascular-announces-14-million-growth-financing-led-by-piper-sandler-merchant-banking-302239766.html
SOURCE Scientia Vascular